524748 — Link Pharmachem Income Statement
0.000.00%
- IN₹148.67m
- IN₹212.46m
- IN₹298.98m
- 63
- 47
- 36
- 47
Annual income statement for Link Pharmachem, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 255 | 348 | 536 | 388 | 299 |
Cost of Revenue | |||||
Gross Profit | 156 | 170 | 171 | 174 | 132 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 230 | 325 | 510 | 370 | 316 |
Operating Profit | 24.9 | 22.7 | 26.1 | 17.9 | -16.8 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 14.4 | 16.8 | 26.2 | 8.86 | -19.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.5 | 10.8 | 18.8 | 6.54 | -13.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 9.5 | 10.8 | 18.8 | 6.54 | -13.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.5 | 10.8 | 18.8 | 6.54 | -13.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.35 | 2.68 | 4.05 | 1.47 | -3.18 |